Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (111-120 of 403) with videos related to

Pageof 41
Sort By:
Plos One|July 14, 2021
Knowledge, beliefs and practices regarding prevention of bacterial meningitis in Burkina Faso, 5 years after MenAfriVac mass campaignsJudith E Mueller, Joy Seanehia, Seydou Yaro, et al.
Vaccine|May 30, 2006
Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunitySharif Uddin, Ray Borrow, Mansel R Haeney, et al.
Journal of Infection and Public Health|March 8, 2025
Genetically distinct Hajj and South American-related strains of serogroup W Neisseria meningitidis causing invasive meningococcal disease in Ontario, Canada, January 1, 2015 to June 30, 2024Courtney Meilleur, Julianne Kus, Christine Navarro, et al.
The Journal of Infection|January 1, 2018
Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and WalesSarah Collins, David Litt, Rachael Almond, et al.
Expert Review of Anti-Infective Therapy|August 7, 2007
On the neisserial vaccine quest: Neisseria Vaccines 2007Rolando Pajón, Olivia Niebla, Daniel Yero, et al.
The Journal of Infection|July 22, 2014
Preventing secondary cases of invasive meningococcal capsular group B (MenB) disease using a recently-licensed, multi-component, protein-based vaccine (Bexsero(®))Shamez N Ladhani, Rebecca Cordery, Sema Mandal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2013
Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and WalesShamez N Ladhani, Nick J Andrews, Pauline Waight, et al.
Clinical and Vaccine Immunology : CVI|October 2, 2008
Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination eraCaroline L Trotter, Ray Borrow, Jamie Findlow, et al.
Pediatrics|September 3, 2017
Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term EculizumabSydel R Parikh, Jay Lucidarme, Coralie Bingham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2012
Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and walesShamez N Ladhani, Nick J Andrews, Pauline Waight, et al.
Pageof 41

Showing results (111-120 of 403) with videos related to

Sort By:
Pageof 41
Plos One|July 14, 2021
Knowledge, beliefs and practices regarding prevention of bacterial meningitis in Burkina Faso, 5 years after MenAfriVac mass campaignsJudith E Mueller, Joy Seanehia, Seydou Yaro, et al.
Vaccine|May 30, 2006
Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunitySharif Uddin, Ray Borrow, Mansel R Haeney, et al.
Journal of Infection and Public Health|March 8, 2025
Genetically distinct Hajj and South American-related strains of serogroup W Neisseria meningitidis causing invasive meningococcal disease in Ontario, Canada, January 1, 2015 to June 30, 2024Courtney Meilleur, Julianne Kus, Christine Navarro, et al.
The Journal of Infection|January 1, 2018
Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and WalesSarah Collins, David Litt, Rachael Almond, et al.
Expert Review of Anti-Infective Therapy|August 7, 2007
On the neisserial vaccine quest: Neisseria Vaccines 2007Rolando Pajón, Olivia Niebla, Daniel Yero, et al.
The Journal of Infection|July 22, 2014
Preventing secondary cases of invasive meningococcal capsular group B (MenB) disease using a recently-licensed, multi-component, protein-based vaccine (Bexsero(®))Shamez N Ladhani, Rebecca Cordery, Sema Mandal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2013
Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and WalesShamez N Ladhani, Nick J Andrews, Pauline Waight, et al.
Clinical and Vaccine Immunology : CVI|October 2, 2008
Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination eraCaroline L Trotter, Ray Borrow, Jamie Findlow, et al.
Pediatrics|September 3, 2017
Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term EculizumabSydel R Parikh, Jay Lucidarme, Coralie Bingham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2012
Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and walesShamez N Ladhani, Nick J Andrews, Pauline Waight, et al.
Pageof 41